No headlines found.
No press releases found.
No news found.
The investment seeks long-term growth of capital. Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies in the healthcare sector. It invests significantly in early-stage companies within the healthcare equipment and supplies, pharmaceuticals, biotechnology, and life sciences industries that are not yet consistently profitable.
Principal Healthcare Innovators ETF trades on the NASDAQ stock market under the symbol BTEC.
As of April 22, 2024, BTEC stock price climbed to $33.93 with 411 million shares trading.
BTEC has a market cap of $39.70 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, BTEC stock traded as high as $61.93 and as low as $25.66.
BTEC has underperformed the market in the last year with a price return of -3.9% while the SPY ETF gained +22.3%. BTEC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -3.8% and -7.7%, respectively, while the SPY returned +3.9% and -3.6%, respectively.
BTEC support price is $32.91 and resistance is $34.13 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BTEC stock will trade within this expected range on the day.